Table 1.
Age, localisation, therapies, and results of all patients with diagnosis of cholangiocarcinoma.
| Variables | Total | (n) | Women | (n) | Men | (n) |
|---|---|---|---|---|---|---|
| (n = 195) | (n = 84) | (n = 111) | ||||
| Median age at point of diagnosis | 58.47 (±12.28) | 56.83 (±10.74) | 59.70 (±13.24) | |||
| Median age at point of death | 59.62 (±11.97) | 58.12 (±11.03) | 60.71 (±12.57) | |||
| Localisation | ||||||
| C22.1 | 111 (56.9%) | 48 (57.1%) | 63 (56.8%) | |||
| C24.0 | 84 (43.1%) | 36 (42.9%) | 48 (43.2%) | |||
| Therapy | ||||||
| OP | 63 (34.1%) | (n = 185) | 28 (35.4%) | (n = 79) | 35 (33.0%) | (n = 106) |
| adjuvant chemotherapy | 15 (8.2%) | (n = 183) | 7 (9.0%) | (n = 78) | 8 (7.6%) | (n = 105) |
| photodynamic therapy | 14 (7.7%) | (n = 183) | 6 (7.6%) | (n = 79) | 8 (7.7%) | (n = 104) |
| TACE | 18 (9.8%) | (n = 183) | 12 (15.2%) | (n = 79) | 6 (5.8%) | (n = 104) |
| chemotherapy | 137 (80.6%) | (n = 170) | 60 (83.3%) | (n = 72) | 77 (78.6%) | (n = 98) |
| Results of therapy | (n = 184) | (n = 81) | (n = 103) | |||
| no tumor | 11 (6.0%) | 7 (8.6%) | 4 (3.9%) | |||
| complete remission | 6 (3.3%) | 4 (4.9%) | 2 (1.9%) | |||
| partial remission | 4 (2.2%) | 1 (1.2%) | 3 (2.9%) | |||
| Reduction of tumor mass without def. Rem. | 6 (3.3%) | 1 (1.2%) | 5 (4.9%) | |||
| unchanged | 8 (4.3%) | 2 (2.5%) | 6 (5.8%) | |||
| progress | 140 (76.1%) | 62 (76.5%) | 78 (75.7%) | |||
| no result of primary therapy | 9 (4.9%) | 4 (4.9%) | 5 (4.9%) | |||
| Survival after | (n = 195) | (n = 84) | (n = 111) | |||
| 3 months | 165 (84.6%) | 74 (88.1%) | 91 (82.0%) | |||
| 6 months | 140 (71.8%) | 65 (77.4%) | 75 (67.6%) | |||
| 12 months | 99 (50.8%) | 47 (56.0%) | 52 (46.8%) | |||
| Event of death | 154 (80.6%) | (n = 191) | 65 (80.2%) | (n = 81) | 89 (80.9%) | (n = 110) |